 |
Alacris Theranostics
Last updated: May 06, 2024
Bodo Lange, CEO and Hans Lehrach, Founder, Chairman
Country: Germany | Add Funding
Website: http://www.alacris.de/
Alacris Theranostics’ mission is to exploit next generation sequencing and other omics data through its predictive modelling system ModCell, to facilitate drug development and personalised medicine in oncology and other complex diseases. This approach was originally developed at the Max Planck Institute for Molecular Genetics in Berlin and is exclusively licensed to Alacris Theranostics.
Website: http://www.alacris.de/
Alacris Theranostics’ mission is to exploit next generation sequencing and other omics data through its predictive modelling system ModCell, to facilitate drug development and personalised medicine in oncology and other complex diseases. This approach was originally developed at the Max Planck Institute for Molecular Genetics in Berlin and is exclusively licensed to Alacris Theranostics.
